Seeking To Redefine What Is Possiblea Promentis Pharmaceuticalsinc Is A Privately Held Biopharmaceutical Company Focused On The Discovery And Development Of First In Class Therapies To Treat Central Nervous Systemcnsdisorders Promentisdrug Development Program Is Focused On Activating A Unique Target Known To Restore Glutamatergic Neurotransmission And Imbalances In Oxidative Stresskey Contributors To Impaired Cortical Function Linked To Multiple Cns Disorders The Company S Lead Compoundsxc 2023Is Being Developed To Treat Various Psychiatric Disorderswith An Initial Focus On An Indication Thatdespite Representing A Common Disorder Affecting Millions Of Patientshas No Fda Approved Treatment And A High Level Of Patient Need
